Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness

  1. Oluwaseun Akeju  Is a corresponding author
  2. Marco L Loggia
  3. Ciprian Catana
  4. Kara J Pavone
  5. Rafael Vazquez
  6. James Rhee
  7. Violeta Contreras Ramirez
  8. Daniel B Chonde
  9. David Izquierdo-Garcia
  10. Grae Arabasz
  11. Shirley Hsu
  12. Kathleen Habeeb
  13. Jacob M Hooker
  14. Vitaly Napadow
  15. Emery Brown
  16. Patrick L Purdon
  1. Massachusetts General Hospital, Harvard Medical School, United States
  2. MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, United States
  3. Massachusetts General Hospital, United States
  4. Massachusetts Institute of Technology, United States

Abstract

Understanding the neural basis of consciousness is fundamental to neuroscience research. Disruptions in cortico-cortical connectivity have been suggested as a primary mechanism of unconsciousness. By using a novel combination of positron emission tomography and functional magnetic resonance imaging, we studied anesthesia-induced unconsciousness and recovery using the α2-agonist dexmedetomidine. During unconsciousness, cerebral metabolic rate of glucose and cerebral blood flow were preferentially decreased in the thalamus, the Default Mode Network (DMN), and the bilateral Frontoparietal Networks (FPNs). Cortico-cortical functional connectivity within the DMN and FPNs was preserved. However, DMN thalamo-cortical functional connectivity was disrupted. Recovery from this state was associated with sustained reduction in cerebral blood flow, and restored DMN thalamo-cortical functional connectivity. We report that loss of thalamo-cortical functional connectivity is sufficient to produce unconsciousness.

Article and author information

Author details

  1. Oluwaseun Akeju

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    For correspondence
    oluwaseun.akeju@mgh.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Marco L Loggia

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Ciprian Catana

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Kara J Pavone

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Rafael Vazquez

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. James Rhee

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Violeta Contreras Ramirez

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Daniel B Chonde

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. David Izquierdo-Garcia

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Grae Arabasz

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Shirley Hsu

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Kathleen Habeeb

    Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Jacob M Hooker

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Vitaly Napadow

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Emery Brown

    Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Patrick L Purdon

    Massachusetts Institute of Technology, Cambridge,, United States
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Human subjects: The Human Research Committee and the Radioactive Drug Research Committee at the Massachusetts General Hospital approved the study protocol. After an initial email/phone screen, potential study subjects were invited to participate in a screening visit. At the screening visit, informed consent including the consent to publish was requested after the nature and possible consequences of the study was explained. All subjects provided informed consent and were American Society of Anesthesiology Physical Status I with Mallampati Class I airway anatomy.

Copyright

© 2014, Akeju et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,513
    views
  • 686
    downloads
  • 138
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Oluwaseun Akeju
  2. Marco L Loggia
  3. Ciprian Catana
  4. Kara J Pavone
  5. Rafael Vazquez
  6. James Rhee
  7. Violeta Contreras Ramirez
  8. Daniel B Chonde
  9. David Izquierdo-Garcia
  10. Grae Arabasz
  11. Shirley Hsu
  12. Kathleen Habeeb
  13. Jacob M Hooker
  14. Vitaly Napadow
  15. Emery Brown
  16. Patrick L Purdon
(2014)
Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness
eLife 3:e04499.
https://doi.org/10.7554/eLife.04499

Share this article

https://doi.org/10.7554/eLife.04499

Further reading

    1. Neuroscience
    Maren Klingelhöfer-Jens, Katharina Hutterer ... Tina B Lonsdorf
    Research Article

    Childhood adversity is a strong predictor of developing psychopathological conditions. Multiple theories on the mechanisms underlying this association have been suggested which, however, differ in the operationalization of ‘exposure.’ Altered (threat) learning mechanisms represent central mechanisms by which environmental inputs shape emotional and cognitive processes and ultimately behavior. 1402 healthy participants underwent a fear conditioning paradigm (acquisition training, generalization), while acquiring skin conductance responses (SCRs) and ratings (arousal, valence, and contingency). Childhood adversity was operationalized as (1) dichotomization, and following (2) the specificity model, (3) the cumulative risk model, and (4) the dimensional model. Individuals exposed to childhood adversity showed blunted physiological reactivity in SCRs, but not ratings, and reduced CS+/CS- discrimination during both phases, mainly driven by attenuated CS+ responding. The latter was evident across different operationalizations of ‘exposure’ following the different theories. None of the theories tested showed clear explanatory superiority. Notably, a remarkably different pattern of increased responding to the CS- is reported in the literature for anxiety patients, suggesting that individuals exposed to childhood adversity may represent a specific sub-sample. We highlight that theories linking childhood adversity to (vulnerability to) psychopathology need refinement.

    1. Genetics and Genomics
    2. Neuroscience
    Monique Marylin Alves de Almeida, Yves De Repentigny ... Rashmi Kothary
    Research Article

    Spinal muscular atrophy (SMA) is caused by mutations in the Survival Motor Neuron 1 (SMN1) gene. While traditionally viewed as a motor neuron disorder, there is involvement of various peripheral organs in SMA. Notably, fatty liver has been observed in SMA mouse models and SMA patients. Nevertheless, it remains unclear whether intrinsic depletion of SMN protein in the liver contributes to pathology in the peripheral or central nervous systems. To address this, we developed a mouse model with a liver-specific depletion of SMN by utilizing an Alb-Cre transgene together with one Smn2B allele and one Smn1 exon 7 allele flanked by loxP sites. Initially, we evaluated phenotypic changes in these mice at postnatal day 19 (P19), when the severe model of SMA, the Smn2B/- mice, exhibit many symptoms of the disease. The liver-specific SMN depletion does not induce motor neuron death, neuromuscular pathology or muscle atrophy, characteristics typically observed in the Smn2B/- mouse at P19. However, mild liver steatosis was observed, although no changes in liver function were detected. Notably, pancreatic alterations resembled that of Smn2B/-mice, with a decrease in insulin-producing β-cells and an increase in glucagon-producingα-cells, accompanied by a reduction in blood glucose and an increase in plasma glucagon and glucagon-like peptide (GLP-1). These changes were transient, as mice at P60 exhibited recovery of liver and pancreatic function. While the mosaic pattern of the Cre-mediated excision precludes definitive conclusions regarding the contribution of liver-specific SMN depletion to overall tissue pathology, our findings highlight an intricate connection between liver function and pancreatic abnormalities in SMA.